Polar Capital Holdings PLC Day One Biopharmaceuticals, Inc. Transaction History

Polar Capital Holdings PLC

$16.3 Billion
Q4 2024

A detailed history of Polar Capital Holdings PLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 185,000 shares of DAWN stock, worth $1.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

185,000

Previous 185,000 -0.0%

Holding current value

$1.49 Million

Previous $2.58 Million 9.08%

% of portfolio

0.01%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$12.72 - $16.03 $9.54 Million - $12 Million	-750,000 Reduced 80.21%	185,000 $2.58 Million
Q2 2024 Aug 14, 2024	SELL	$12.03 - $17.69 $3.01 Million - $4.42 Million	-250,000 Reduced 21.1%	935,000 $12.9 Million
Q1 2024 May 15, 2024	SELL	$13.56 - $17.46 $2.71 Million - $3.49 Million	-200,000 Reduced 14.44%	1,185,000 $19.6 Million
Q4 2023 Feb 14, 2024	SELL	$9.68 - $15.37 $5.32 Million - $8.45 Million	-550,000 Reduced 28.42%	1,385,000 $20.2 Million
Q3 2023 Nov 14, 2023	BUY	$11.22 - $14.86 $1.8 Million - $2.38 Million	160,385 Added 9.04%	1,935,000 $23.7 Million
Q2 2023 Dec 13, 2023	BUY	$11.74 - $14.47 $4.4 Million - $5.43 Million	375,067 Added 26.8%	1,774,615 $21.2 Million
Q2 2023 Aug 14, 2023	BUY	$11.74 - $14.47 $4.4 Million - $5.43 Million	375,067 Added 26.8%	1,774,615 $21.2 Million
Q1 2023 Dec 13, 2023	SELL	$12.75 - $23.41 $6.83 Million - $12.5 Million	-535,452 Reduced 27.67%	1,399,548 $18.7 Million
Q4 2022 Feb 14, 2023	BUY	$18.77 - $22.0 $3.08 Million - $3.61 Million	163,973 Added 13.27%	1,399,548 $30.1 Million
Q3 2022 Nov 14, 2022	BUY	$16.44 - $26.57 $4.34 Million - $7.01 Million	263,879 Added 27.16%	1,235,575 $24.7 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $17.9 $5.56 Million - $17.4 Million	971,696 New	971,696 $17.4 Million

Others Institutions Holding DAWN

# of Institutions

175

Shares Held

77.1M

Call Options Held

139K

Put Options Held

253K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $593M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account

Polar Capital Holdings PLC Day One Biopharmaceuticals, Inc. Transaction History